» Articles » PMID: 35571023

A View on Genomic Medicine Activities in Africa: Implications for Policy

Abstract

Genomics policy development involves assessing a wide range of issues extending from specimen collection and data sharing to whether and how to utilize advanced technologies in clinical practice and public health initiatives. A survey was conducted among African scientists and stakeholders with an interest in genomic medicine, seeking to evaluate: 1) Their knowledge and understanding of the field. 2) The institutional environment and infrastructure available to them. 3) The state and awareness of the field in their country. 4) Their perception of potential barriers to implementation of precision medicine. We discuss how the information gathered in the survey could instruct the policies of African institutions seeking to implement precision, and more specifically, genomic medicine approaches in their health care systems in the following areas: 1) Prioritization of infrastructures. 2) Need for translational research. 3) Information dissemination to potential users. 4) Training programs for specialized personnel. 5) Engaging political stakeholders and the public. A checklist with key requirements to assess readiness for implementation of genomic medicine programs is provided to guide the process from scientific discovery to clinical application.

Citing Articles

Pharmacogenomics of Chemotherapies for Childhood Cancers in Africa: A Scoping Review.

Katabalo D, Mwita S, Liwa A, Kidenya B, Schroeder K Pharmgenomics Pers Med. 2025; 18:55-69.

PMID: 39968370 PMC: 11834739. DOI: 10.2147/PGPM.S502355.


Data sharing: A Long COVID perspective, challenges, and road map for the future.

Oladejo S, Watson L, Watson B, Rajaratnam K, Kotze M, Kell D S Afr J Sci. 2024; 119(5-6):73-80.

PMID: 39324014 PMC: 11423650. DOI: 10.17159/sajs.2023/14719.


Building genomic capacity for precision health in Africa.

Olono A, Mitesser V, Happi A, Happi C Nat Med. 2024; 30(7):1856-1864.

PMID: 38961224 DOI: 10.1038/s41591-024-03081-9.


Review of Genetic and Artificial Intelligence approaches to improving Gestational Diabetes Mellitus Screening and Diagnosis in sub-Saharan Africa.

Gadhia V, Loyal J Yale J Biol Med. 2024; 97(1):67-72.

PMID: 38559462 PMC: 10964814. DOI: 10.59249/ZBSC2656.


A regionally based precision medicine implementation initiative in North Africa:The PerMediNA consortium.

Hamdi Y, Boujemaa M, Ben Aissa-Haj J, Radouani F, Khyatti M, Mighri N Transl Oncol. 2024; 44:101940.

PMID: 38537326 PMC: 11391035. DOI: 10.1016/j.tranon.2024.101940.


References
1.
Roberts M, Fohner A, Landry L, Olstad D, Smit A, Turbitt E . Advancing precision public health using human genomics: examples from the field and future research opportunities. Genome Med. 2021; 13(1):97. PMC: 8168000. DOI: 10.1186/s13073-021-00911-0. View

2.
Fontes Marx M, Ataguba J, de Vries J, Wonkam A . Systematic Review of the Economic Evaluation of Returning Incidental Findings in Genomic Research. Front Public Health. 2021; 9:697381. PMC: 8281014. DOI: 10.3389/fpubh.2021.697381. View

3.
Kristensen N, Nymann C, Konradsen H . Implementing research results in clinical practice- the experiences of healthcare professionals. BMC Health Serv Res. 2016; 16:48. PMC: 4748469. DOI: 10.1186/s12913-016-1292-y. View

4.
Glanzmann B, Jooste T, Ghoor S, Gordon R, Mia R, Mao J . Human whole genome sequencing in South Africa. Sci Rep. 2021; 11(1):606. PMC: 7803990. DOI: 10.1038/s41598-020-79794-x. View

5.
Myburgh E, de Jager J, Murray E, Grant K, Kotze M, de Klerk H . The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa. Breast. 2021; 59:87-93. PMC: 8259301. DOI: 10.1016/j.breast.2021.05.010. View